Danbee Kang1,2, Genehee Lee1,3, Sooyeon Kim1,2, Heesu Nam1,2, Sunga Kong1,3, Sungkeun Shim4, Jae Kyung Lee3, Wonyoung Jung5, Sumin Shin6, Hong Kwan Kim6, Jae Ill Zo6, Young Mog Shim6, Dong Wook Shin1,4,5, Juhee Cho1,2,4. 1. Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea. 2. Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea. 3. Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Korea. 4. Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea. 5. Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 6. Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract
PURPOSE: The purpose of the study was to validate the Korean version of Cancer Survivors' Unmet Needs (CaSUN) scale among non-small cell lung cancer (NSCLC) survivors. MATERIALS AND METHODS: Participants were recruited from outpatient clinics at the Samsung Medical Center in Seoul, South Korea, from January to October 2020. Participants completed a survey questionnaire that included the CaSUN. Exploratory and confirmatory factor analysis (EFA, CFA) and Pearson's correlations were used to evaluate the reliability and validity of the CaSUN-K. We also tested known-group validity using an independent t-test or ANOVA. RESULTS: In total, 949 provided informed consent and all of which completed the questionnaire. Among the 949 patients, 529 (55.7%) were male; the mean age and median time since the end of active treatment (SD) was 63.4 (8.7) years and the median was 18 months. Although the factor loadings were different from those for the original scale, the Cronbach's alpha coefficients of the 6 domains in the CaSUN-K ranged from 0.68 to 0.95, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the CaSUN-K were high. Moderate correlations demonstrated the convergent validity of CaSUN-K with the relevant questionnaire. More than 60% of the participants reported information-related unmet needs, and the CaSUN-K discriminated between the needs reported by the different subgroups that we analyzed. CONCLUSION: The CaSUN-K is a reliable and valid measure for assessing the unmet needs in a cancer population, thus this tool help population to receive timely, targeted, and relevant care.
PURPOSE: The purpose of the study was to validate the Korean version of Cancer Survivors' Unmet Needs (CaSUN) scale among non-small cell lung cancer (NSCLC) survivors. MATERIALS AND METHODS: Participants were recruited from outpatient clinics at the Samsung Medical Center in Seoul, South Korea, from January to October 2020. Participants completed a survey questionnaire that included the CaSUN. Exploratory and confirmatory factor analysis (EFA, CFA) and Pearson's correlations were used to evaluate the reliability and validity of the CaSUN-K. We also tested known-group validity using an independent t-test or ANOVA. RESULTS: In total, 949 provided informed consent and all of which completed the questionnaire. Among the 949 patients, 529 (55.7%) were male; the mean age and median time since the end of active treatment (SD) was 63.4 (8.7) years and the median was 18 months. Although the factor loadings were different from those for the original scale, the Cronbach's alpha coefficients of the 6 domains in the CaSUN-K ranged from 0.68 to 0.95, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the CaSUN-K were high. Moderate correlations demonstrated the convergent validity of CaSUN-K with the relevant questionnaire. More than 60% of the participants reported information-related unmet needs, and the CaSUN-K discriminated between the needs reported by the different subgroups that we analyzed. CONCLUSION: The CaSUN-K is a reliable and valid measure for assessing the unmet needs in a cancer population, thus this tool help population to receive timely, targeted, and relevant care.